Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
MRK
MRK
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest MRK ETF News Today | Earnings, Events & Price Alerts
MRK News
Merck & Co Inc: FDA Establishes PDUFA Deadline of June 19, 2026 for Welireg and Keytruda
2d ago
moomoo
FDA Grants Priority Review for Combination of Welireg and Keytruda by Merck & Co Inc.
2d ago
moomoo
Combination of KEYTRUDA® (PEMBROLIZUMAB) and WELIREG® (BELZUTIFAN) as Adjuvant Therapy Lowers Risk of Disease Recurrence or Death by 28% Compared to KEYTRUDA Monotherapy in Certain Early-Stage Renal Cell Carcinoma Patients
2d ago
moomoo
MERCK & CO INC - FDA AGREES TO EVALUATE TWO ADDITIONAL NDAs FOR WELIREG IN COMBINATION WITH LENVIMA
2d ago
moomoo
MERCK & CO INC - WELIREG COMBINED WITH LENVIMA DEMONSTRATES NOTABLE ENHANCEMENT IN PROGRESSION-FREE SURVIVAL
2d ago
moomoo
MERCK & CO INC - WELIREG COMBINED WITH LENVIMA LOWERS DISEASE PROGRESSION RISK BY 30%
2d ago
moomoo
WELIREG® (BELZUTIFAN) AND LENVIMA® (LENVATINIB) LOWERED THE RISK OF DISEASE PROGRESSION OR DEATH BY 30% IN SELECTED PREVIOUSLY TREATED PATIENTS WITH ADVANCED RENAL CELL CARCINOMA (RCC) WHEN COMPARED TO CABOZANTINIB.
2d ago
moomoo
Analysis of Growth Drivers in the Biliary Tract Cancer Market
4h ago
Newsfilter
ImmunityBio's 2025 Outlook Shows Positive Trends
20h ago
stocktwits
Merck and Eisai Present New Data on Kidney Cancer Therapy
2d ago
Businesswire
Merck's KEYTRUDA and WELIREG Show Promising Results in Kidney Cancer Treatment
2d ago
Businesswire
WELIREG and KEYTRUDA Combination Shows Positive Phase 3 Results in Kidney Cancer
2d ago
Newsfilter
Exelixis Aims to Expand Beyond Cabozantinib Franchise
2d ago
NASDAQ.COM
Exelixis Aims to Become a Top Oncology Player with Expanding Pipeline
2d ago
Fool
Merck to Lay Off 150 Employees Amid Vaccine Sales Decline
3d ago
Newsfilter
Merck's Keytruda Significantly Improves Survival in Ovarian Cancer Patients
3d ago
seekingalpha
Show More News
